Developer docs
API playgroundTry for free, no card

Search company profiles

ILife Consulting

Full company profile

uuid000apcs

Namestring
ILife Consulting
Legal namestring
ILife Consulting S.A.S.
Company typeenum
Private
Founded yearint
2013
Descriptiontext

ILife Consulting S.A.S. is a Paris-based, full-service Contract Research Organisation founded in 2013 by Marina Iché, providing clinical development services to small and mid-sized European and North American biotech companies. Its core offerings are organized into four pillars: Clinical Development Strategy, Clinical Study Conduct (CRO activity), Clinical Oversight, and Clinical Operations Externalization, supported by service modules in scientific/medical writing, clinical monitoring and site management, project management (including CTIS submissions), clinical gap analysis, and recruitment/training. The firm specializes in Phase I and Phase II trials, with particular depth in oncology (including basket studies), rare diseases, and innovative modalities such as cell therapy, gene therapy, monoclonal antibodies, and vaccines.

Underlying technology comprises a user-friendly Clinical Trial Management System (CTMS) and partnerships for electronic data capture (eCRF), eDiary/eCOA, IRT, and eTMF systems, with risk-based monitoring and risk-adapted quality management. The delivery model blends an office-based core team of Clinical Research Associates, Project Managers, and Therapeutic/Regulatory Directors with a network of long-term freelance CRA collaborators across Europe, augmented by North American CRO partnerships for US and Canada site monitoring.

Commercially, ILife operates on a professional-services, quote-based engagement model with no publicly disclosed pricing tiers. GTM is enterprise field sales driven by direct outreach, industry conferences, ecosystem memberships (notably the Paris Saclay Cancer Cluster), and a heavily referral-driven funnel — the firm reports that 90% of clients are repeats or referrals, with 20+ active clients, 1000+ patients treated, and 1500+ monitoring visits. Since June 3, 2025, ILife Consulting has operated as a subsidiary of Comac Medical Group within a pan-European full-service CRO platform.

Short descriptiontext

ILife Consulting is a Paris-based full-service CRO providing Phase I/II clinical development, monitoring, oversight, and clinical operations externalization primarily to small and mid-sized European and North American biotechs, with deep specialization in oncology and rare diseases.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, biotech CRO services, clinical trial management, clinical development consulting, contract research organization
Industry3 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Organization (CRO) Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Operations Services
TypeProfessional Services
Description

Full-service CRO providing clinical development strategy, clinical study conduct, clinical oversight, and clinical operations externalization. Services include project management, clinical monitoring, regulatory submissions, vendor management, and training/upskilling.

ilifeconsulting.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ILife Consulting operates as a full-service Contract Research Organisation (CRO) providing comprehensive clinical trial solutions for biotech companies. It delivers four core service areas: Clinical Operations Externalization, Clinical Development Strategy, Clinical Study Conduct, and Clinical Oversight, supported by modules including scientific and medical writing, clinical monitoring and site management, recruitment and training, clinical gap analysis, and project management. Services span feasibility through Clinical Study Report delivery for small and mid-sized life science companies developing innovative therapies, primarily in oncology and rare diseases.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 90% of clients are repeats or referrals
+3 more records
Product overview1 text field

ILife Consulting operates as a full-service Contract Research Organisation (CRO) providing comprehensive clinical trial solutions to biotech companies. The company offers a unified platform of clinical development services comprising four core service areas: Clinical Operations Externalization, Clinical Development Strategy, Clinical Study Conduct (CRO activity), and Clinical Oversight. These core offerings are supplemented by specialized service modules including Scientific and Medical Writing, Clinical Monitoring & Site Management, Recruitment and Training, Clinical Gap Analysis, and Project Management. The platform enables small and mid-sized life science companies to externalize or enhance their clinical operations through tailored, value-creating solutions spanning feasibility assessments through Clinical Study Report delivery.

Product and service9 records
1Clinical Operations Externalization
CategoryClinical Operations Outsourcing
Description

Full externalization of clinical operations for small and mid-sized life science companies, including day-to-day clinical operations management, participation in executive committees, board meetings, and investigator meetings. Intended for biotech sponsors that lack or choose not to staff full internal clinical operations teams.

2Clinical Development Strategy
CategoryClinical Development Consulting
Description

Customized clinical development strategy services, including basket study design, expert and vendor identification, regulatory submission assistance, and risk analyses. Designed to create value and meet biotech client objectives across small molecules, mAbs, cell therapy, gene therapy, and vaccines.

3Clinical Study Conduct (CRO activity)
CategoryContract Research Organization Services
Description

Full CRO activity encompassing study startup, regulatory submissions, project management, risk management, vendor management, and clinical monitoring and site management across Europe. Delivered for sponsors needing end-to-end clinical trial execution.

4Clinical Oversight
CategoryClinical Oversight Consulting
Description

Clinical consulting services to de-risk clinical trials when conducted by another selected CRO, including CRO selection assistance, coordination, supervision, and strategic clinical input. Aimed at sponsors that retain ILife as an independent strategic advisor while another CRO executes the trial.

5Scientific and Medical Writing
CategoryScientific and Medical Writing
Description

Development of clinical documentation including synopsis, protocol, monitoring plan, Informed Consent Form, Pharmacy Manual, SOPs, and Case Report Forms. Supports biotech clients and investigative teams preparing clinical trial materials.

6Clinical Monitoring and Site Management
CategoryClinical Monitoring Services
Description

On-site and remote clinical monitoring in accordance with ICH-GCP standards, including risk-based monitoring, site training, and performance management throughout Europe. Delivered by office-based and freelance CRA collaborators.

7Recruitment and Training
CategoryTraining and Capacity Building
Description

Training and upskilling of Clinical Operations collaborators to regulatory and GCP standards, delivered by seasoned Clinical Project Managers. Tailored for biotech sponsors building or reinforcing internal clinical operations capability.

8Clinical Gap Analysis
CategoryClinical Quality Consulting
Description

Proactive review of clinical study processes and procedures to identify potential sources of dysfunction, evaluate performances, and ensure optimal conduct of clinical studies. Used to support trial rescue engagements and quality improvement initiatives.

9Project Management
CategoryClinical Project Management
Description

Centralized project management from study initiation to close out, including CTMS administration, vendor management, CTA submissions via CTIS, and regulatory authority support, serving biotech sponsors needing a single accountable project owner.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeOthersAnnounced on2025-06-03
Description

ILife Consulting was acquired by Comac Medical Group on June 3, 2025, in Paris. The acquisition brings clients enhanced clinical development and regulatory expertise within a pan-European full-service CRO platform. McDermott advised ILife Consulting on the acquisition.

Strategic tierCoreTypeOthers
Description

ILife Consulting is part of Comac Medical Group, bringing clients enhanced clinical development and regulatory expertise within a pan-European full-service CRO platform. Described as a sister company.

3Niche CRO Partners
Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Established partnerships with niche CROs in selected countries and North America to meet the market strategy and operational needs of clients.

ilifeconsulting.com
Strategic tierSupportingTypeTechnology or Integration
Description

Partnerships with data management, statistics, vigilance service providers, eSolutions providers (eCRF, eDiary/eCOA, IRT, eTMF), clinical trial supplies and operational supplies vendors.

Strategic tierSupportingTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with a global, exemplary Oncology clinical trial sites network to support oncology trial execution.

6Paris Saclay Cancer Cluster
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Active member of PSCC Connect network, contributing to a collaborative ecosystem that brings together start-ups, scientific experts and leading institutions to accelerate development of next-generation cancer treatments across Europe.

ilifeconsulting.com
Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

Production, management and editorial services provider for the company website.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based, mid-sized full-service CRO focused on small-to-mid biotech sponsors, with strong therapeutic expertise in oncology and early-phase trials — closely matches ILife's biotech-focused, scientifically-led positioning.

TypeDirect peer
Description

Pan-European full-service CRO platform that acquired ILife in June 2025; offers directly overlapping clinical operations, regulatory, and early-phase services to biotech sponsors across Europe.

TypeDirect peer
Description

Mid-sized scientific CRO serving small and mid-sized biotech and pharma; known for therapeutic specialization in oncology and rare disease — a directly comparable specialty CRO peer.

TypeDirect peer
Description

Specialty CRO historically focused on oncology and rare disease for small-mid biotech sponsors; merged with Premier Research after acquisition by Asahi Kasei — directly comparable therapeutic and customer profile.

TypeDirect peer
Description

European-headquartered full-service CRO with strong biotech sponsor focus and therapeutic specialization; directly comparable size, geography, and biotech customer base.

TypeDirect peer
Description

Mid-sized CRO historically serving emerging biotech and mid-sized pharma; comparable in scale and therapeutic focus, particularly in oncology.

TypeDirect peer
Description

Specialty CRO with deep focus on oncology, rare disease, and innovative modalities for small-mid biotech; very comparable customer profile and scientific service orientation.

TypeDirect peer
Description

Mid-sized CRO with strong biotech and oncology focus and academic trial experience; overlapping target customers and therapeutic emphasis.

TypeBroad incumbent
Description

Largest global CRO and life science services firm; competes in clinical operations for biotech sponsors but operates at much greater scale and breadth than ILife.

TypeBroad incumbent
Description

Large global full-service CRO competing for biotech Phase I–IV work; includes specialist biotech-oriented units (e.g., after the PAREXEL split), representing a broad incumbent alternative.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ILife Consulting

Clinical Research Organization (CRO) Servicesilifeconsulting.com

ILife Consulting is a Paris-based full-service CRO providing Phase I/II clinical development, monitoring, oversight, and clinical operations externalization primarily to small and mid-sized European and North American biotechs, with deep specialization in oncology and rare diseases.

What ILife Consulting does

ILife Consulting S.A.S. is a Paris-based, full-service Contract Research Organisation founded in 2013 by Marina Iché, providing clinical development services to small and mid-sized European and North American biotech companies. Its core offerings are organized into four pillars: Clinical Development Strategy, Clinical Study Conduct (CRO activity), Clinical Oversight, and Clinical Operations Externalization, supported by service modules in scientific/medical writing, clinical monitoring and site management, project management (including CTIS submissions), clinical gap analysis, and recruitment/training. The firm specializes in Phase I and Phase II trials, with particular depth in oncology (including basket studies), rare diseases, and innovative modalities such as cell therapy, gene therapy, monoclonal antibodies, and vaccines.

Underlying technology comprises a user-friendly Clinical Trial Management System (CTMS) and partnerships for electronic data capture (eCRF), eDiary/eCOA, IRT, and eTMF systems, with risk-based monitoring and risk-adapted quality management. The delivery model blends an office-based core team of Clinical Research Associates, Project Managers, and Therapeutic/Regulatory Directors with a network of long-term freelance CRA collaborators across Europe, augmented by North American CRO partnerships for US and Canada site monitoring.

Commercially, ILife operates on a professional-services, quote-based engagement model with no publicly disclosed pricing tiers. GTM is enterprise field sales driven by direct outreach, industry conferences, ecosystem memberships (notably the Paris Saclay Cancer Cluster), and a heavily referral-driven funnel — the firm reports that 90% of clients are repeats or referrals, with 20+ active clients, 1000+ patients treated, and 1500+ monitoring visits. Since June 3, 2025, ILife Consulting has operated as a subsidiary of Comac Medical Group within a pan-European full-service CRO platform.

ILife Consulting firmographics

Firmographics
Name
ILife Consulting
Legal name
ILife Consulting S.A.S.
Website
https://ilifeconsulting.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
ILife Consulting is a Paris-based full-service CRO providing Phase I/II clinical development, monitoring, oversight, and clinical operations externalization primarily to small and mid-sized European and North American biotechs, with deep specialization in oncology and rare diseases.
Ownership category
akta.pro rank

ILife Consulting industry classification

Industry
Product category
Clinical Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs

Keywords

  • Clinical research services
  • Biotech CRO services
  • Clinical trial management
  • Clinical development consulting
  • Contract research organization

Where ILife Consulting is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices2 records

Markets served

ILife Consulting business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Operations Services: Full-service CRO providing clinical development strategy, clinical study conduct, clinical oversight, and clinical operations externalization. Services include project management, clinical monitoring, regulatory submissions, vendor management, and training/upskilling.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

ILife Consulting product offering

Product offering

Core offering

ILife Consulting operates as a full-service Contract Research Organisation (CRO) providing comprehensive clinical trial solutions for biotech companies. It delivers four core service areas: Clinical Operations Externalization, Clinical Development Strategy, Clinical Study Conduct, and Clinical Oversight, supported by modules including scientific and medical writing, clinical monitoring and site management, recruitment and training, clinical gap analysis, and project management. Services span feasibility through Clinical Study Report delivery for small and mid-sized life science companies developing innovative therapies, primarily in oncology and rare diseases.

Product overview

ILife Consulting operates as a full-service Contract Research Organisation (CRO) providing comprehensive clinical trial solutions to biotech companies. The company offers a unified platform of clinical development services comprising four core service areas: Clinical Operations Externalization, Clinical Development Strategy, Clinical Study Conduct (CRO activity), and Clinical Oversight. These core offerings are supplemented by specialized service modules including Scientific and Medical Writing, Clinical Monitoring & Site Management, Recruitment and Training, Clinical Gap Analysis, and Project Management. The platform enables small and mid-sized life science companies to externalize or enhance their clinical operations through tailored, value-creating solutions spanning feasibility assessments through Clinical Study Report delivery.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Operations Externalization Full externalization of clinical operations for small and mid-sized life science companies, including day-to-day clinical operations management, participation in executive committees, board meetings, and investigator meetings. Intended for biotech sponsors that lack or choose not to staff full internal clinical operations teams.
  • Clinical Development Strategy Customized clinical development strategy services, including basket study design, expert and vendor identification, regulatory submission assistance, and risk analyses. Designed to create value and meet biotech client objectives across small molecules, mAbs, cell therapy, gene therapy, and vaccines.
  • Clinical Study Conduct (CRO activity) Full CRO activity encompassing study startup, regulatory submissions, project management, risk management, vendor management, and clinical monitoring and site management across Europe. Delivered for sponsors needing end-to-end clinical trial execution.
  • Clinical Oversight Clinical consulting services to de-risk clinical trials when conducted by another selected CRO, including CRO selection assistance, coordination, supervision, and strategic clinical input. Aimed at sponsors that retain ILife as an independent strategic advisor while another CRO executes the trial.
  • Scientific and Medical Writing Development of clinical documentation including synopsis, protocol, monitoring plan, Informed Consent Form, Pharmacy Manual, SOPs, and Case Report Forms. Supports biotech clients and investigative teams preparing clinical trial materials.
  • Clinical Monitoring and Site Management On-site and remote clinical monitoring in accordance with ICH-GCP standards, including risk-based monitoring, site training, and performance management throughout Europe. Delivered by office-based and freelance CRA collaborators.
  • Recruitment and Training Training and upskilling of Clinical Operations collaborators to regulatory and GCP standards, delivered by seasoned Clinical Project Managers. Tailored for biotech sponsors building or reinforcing internal clinical operations capability.
  • Clinical Gap Analysis Proactive review of clinical study processes and procedures to identify potential sources of dysfunction, evaluate performances, and ensure optimal conduct of clinical studies. Used to support trial rescue engagements and quality improvement initiatives.
  • Project Management Centralized project management from study initiation to close out, including CTMS administration, vendor management, CTA submissions via CTIS, and regulatory authority support, serving biotech sponsors needing a single accountable project owner.

Quantifiable outcome

  • 90% of clients are repeats or referrals
  • +3 more outcomes

Companies that use ILife Consulting

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

ILife Consulting technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

ILife Consulting partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and supporting.

  • Comac Medical GroupcoreOthers · 3 June 2025ILife Consulting was acquired by Comac Medical Group on June 3, 2025, in Paris. The acquisition brings clients enhanced clinical development and regulatory expertise within a pan-European full-service CRO platform. McDermott advised ILife Consulting on the acquisition.
  • Comac MedicalcoreOthersILife Consulting is part of Comac Medical Group, bringing clients enhanced clinical development and regulatory expertise within a pan-European full-service CRO platform. Described as a sister company.
  • Niche CRO PartnerssupportingChannel Partner/ Reseller/ DistributorEstablished partnerships with niche CROs in selected countries and North America to meet the market strategy and operational needs of clients.
  • Vendor PartnerssupportingTechnology or IntegrationPartnerships with data management, statistics, vigilance service providers, eSolutions providers (eCRF, eDiary/eCOA, IRT, eTMF), clinical trial supplies and operational supplies vendors.
  • Oncology Clinical Trial Sites NetworksupportingChannel Partner/ Reseller/ DistributorPartnership with a global, exemplary Oncology clinical trial sites network to support oncology trial execution.
  • Paris Saclay Cancer ClustersupportingStrategic or Co-development PartnerActive member of PSCC Connect network, contributing to a collaborative ecosystem that brings together start-ups, scientific experts and leading institutions to accelerate development of next-generation cancer treatments across Europe.
  • ATCG PartnerssupportingImplementation/ SI/ Consulting PartnerProduction, management and editorial services provider for the company website.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

ILife Consulting competitors and assessment

Company assessment

Direct peers

  • Medpace Holdings: US-based, mid-sized full-service CRO focused on small-to-mid biotech sponsors, with strong therapeutic expertise in oncology and early-phase trials — closely matches ILife's biotech-focused, scientifically-led positioning.
  • Comac Medical Group: Pan-European full-service CRO platform that acquired ILife in June 2025; offers directly overlapping clinical operations, regulatory, and early-phase services to biotech sponsors across Europe.
  • Worldwide Clinical Trials: Mid-sized scientific CRO serving small and mid-sized biotech and pharma; known for therapeutic specialization in oncology and rare disease — a directly comparable specialty CRO peer.
  • Ergomed (Asahi Kasei): Specialty CRO historically focused on oncology and rare disease for small-mid biotech sponsors; merged with Premier Research after acquisition by Asahi Kasei — directly comparable therapeutic and customer profile.
  • PSI CRO: European-headquartered full-service CRO with strong biotech sponsor focus and therapeutic specialization; directly comparable size, geography, and biotech customer base.
  • Clinipace Worldwide: Mid-sized CRO historically serving emerging biotech and mid-sized pharma; comparable in scale and therapeutic focus, particularly in oncology.
  • Premier Research: Specialty CRO with deep focus on oncology, rare disease, and innovative modalities for small-mid biotech; very comparable customer profile and scientific service orientation.
  • CTI Clinical Trial & Consulting Services: Mid-sized CRO with strong biotech and oncology focus and academic trial experience; overlapping target customers and therapeutic emphasis.

Broad incumbents

  • IQVIA: Largest global CRO and life science services firm; competes in clinical operations for biotech sponsors but operates at much greater scale and breadth than ILife.
  • Parexel International: Large global full-service CRO competing for biotech Phase I–IV work; includes specialist biotech-oriented units (e.g., after the PAREXEL split), representing a broad incumbent alternative.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

ILife Consulting social profiles

Digital presence

ILife Consulting financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ILife Consulting leadership team

Management profile

Number of profiles

Profiles7 records

ILife Consulting funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ILife Consulting M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ILife Consulting

What does ILife Consulting do?

ILife Consulting operates as a full-service Contract Research Organisation (CRO) providing comprehensive clinical trial solutions for biotech companies. It delivers four core service areas: Clinical Operations Externalization, Clinical Development Strategy, Clinical Study Conduct, and Clinical Oversight, supported by modules including scientific and medical writing, clinical monitoring and site management, recruitment and training, clinical gap analysis, and project management. Services span feasibility through Clinical Study Report delivery for small and mid-sized life science companies developing innovative therapies, primarily in oncology and rare diseases.

Is ILife Consulting a public or private company?

ILife Consulting is a private company. It is classified as corporate owned and is currently operating.

When was ILife Consulting founded?

ILife Consulting was founded in 2013. It employs 11 to 50 people.

Where is ILife Consulting based?

ILife Consulting is headquartered in Paris, France, in the Europe region.

How does ILife Consulting make money?

One revenue line is on record: clinical Operations Services.

Who are ILife Consulting's main competitors?

Direct peers on record are Medpace Holdings, Comac Medical Group, Worldwide Clinical Trials, Ergomed (Asahi Kasei), PSI CRO, Clinipace Worldwide, Premier Research and CTI Clinical Trial & Consulting Services. Broad incumbents are IQVIA and Parexel International.

Does ILife Consulting have an API?

No public API is recorded for ILife Consulting.

What industry is ILife Consulting in?

ILife Consulting's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MweMcDermott Advises ILIFE Consulting on its AcquisitionMcDermott Will & Emery advised ILIFE Consulting on its acquisition by Comac Medical Group, a pan-European CRO. The deal, supported by EdgeCap Partners, integrates ILIFE's early-stage oncology and biotech services with Comac's clinical research capabilities.Comac-MedicalComac Medical Expands with Acquisition of ILIFE Consulting, a French CROComac Medical Group, backed by EdgeCap, acquired ILIFE Consulting, a Paris-based CRO specializing in oncology and early-phase biotech trials. The deal expands the Group's pan-European footprint and adds capabilities in biostatistics, data management, and pharmacovigilance. ILIFE's CEO Marina Iché will remain in her role and become a significant shareholder.The Manila TimesEdgeCap-backed Comac Medical Group Expands with Acquisition of ILIFE Consulting, a French Early-phase Specialty CROComac Medical Group, backed by EdgeCap Partners, acquired ILIFE Consulting, a Paris-based CRO specializing in oncology and early-phase biotech trials. The deal expands the Group's pan-European footprint and adds expertise in biostatistics, data management, and pharmacovigilance. ILIFE's founder Marina Iché will remain CEO and become a significant shareholder.PR NewswireEdgeCap-backed Comac Medical Group Expands with Acquisition of ILIFE Consulting, a French Early-phase Specialty CROComac Medical Group, backed by EdgeCap Partners, acquired ILIFE Consulting, a Paris-based CRO specializing in oncology and early-phase biotech trials. The deal expands the Group's pan-European footprint and adds expertise in biostatistics, data management, and pharmacovigilance. ILIFE's founder Marina Iché will remain CEO and become a significant shareholder.The Globe and MailEdgeCap-backed Comac Medical Group Expands with Acquisition of ILIFE Consulting, a French Early-phase Specialty CROEdgeCap-backed Comac Medical Group acquired ILIFE Consulting, a French early-phase specialty CRO. The strategic acquisition aims to establish a pan-European footprint and deepen expertise in oncology and early-phase biotech clinical trials.